Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Clin Cancer Res. 2020 Nov 9;27(3):865–876. doi: 10.1158/1078-0432.CCR-20-2385

Figure 2A: Expression-level difference of LC3 A/B in human CRC cell lines.

Figure 2A:

Flow cytometry analysis (Flo Jo 9.2) detected higher fold change of LC3 A/B in HCT116 in comparison to Hke3 at 6 and 9 hours (p<0.05) i) The dot plot ii) Histogram iii) Graphical representation. Cells were stained for LC3 A/B and detected through FITC channel. The fold change of each cell line was obtained by normalizing the pelareorep treated samples to the untreated counterparts (n=4).